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Abstract
Background:  Accurate identification of hypoglycemia cases by International Classification of
Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) codes will help to describe epidemiology,
monitor trends, and propose interventions for this important complication in patients with
diabetes. Prior hypoglycemia studies utilized incomplete search strategies and may be
methodologically flawed. We sought to validate a new ICD-9-CM coding algorithm for accurate
identification of hypoglycemia visits.
Methods: This was a multicenter, retrospective cohort study using a structured medical record
review at three academic emergency departments from July 1, 2005 to June 30, 2006. We
prospectively derived a coding algorithm to identify hypoglycemia visits using ICD-9-CM codes
(250.3, 250.8, 251.0, 251.1, 251.2, 270.3, 775.0, 775.6, and 962.3). We confirmed hypoglycemia
cases by chart review identified by candidate ICD-9-CM codes during the study period. The case
definition for hypoglycemia was documented blood glucose 3.9 mmol/l or emergency physician
charted diagnosis of hypoglycemia. We evaluated individual components and calculated the positive
predictive value.
Results: We reviewed 636 charts identified by the candidate ICD-9-CM codes and confirmed 436
(64%) cases of hypoglycemia by chart review. Diabetes with other specified manifestations (250.8),
often excluded in prior hypoglycemia analyses, identified 83% of hypoglycemia visits, and
unspecified hypoglycemia (251.2) identified 13% of hypoglycemia visits. The absence of any
predetermined co-diagnosis codes improved the positive predictive value of code 250.8 from 62%
to 92%, while excluding only 10 (2%) true hypoglycemia visits. Although prior analyses included only
the first-listed ICD-9 code, more than one-quarter of identified hypoglycemia visits were outside
this primary diagnosis field. Overall, the proposed algorithm had 89% positive predictive value (95%
confidence interval, 86–92) for detecting hypoglycemia visits.
Conclusion: The proposed algorithm improves on prior strategies to identify hypoglycemia visits
in administrative data sets and will enhance the ability to study the epidemiology and design
interventions for this important complication of diabetes care.
Published: 1 April 2008
BMC Endocrine Disorders 2008, 8:4 doi:10.1186/1472-6823-8-4
Received: 4 December 2007
Accepted: 1 April 2008
This article is available from: http://www.biomedcentral.com/1472-6823/8/4
© 2008 Ginde et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.BMC Endocrine Disorders 2008, 8:4 http://www.biomedcentral.com/1472-6823/8/4
Page 2 of 7
(page number not for citation purposes)
Background
Hypoglycemia is an important complication in patients
with diabetes that has a profound impact on quality of life
and self-management. While tight glycemic control
remains a hallmark to lower rates of complications [1-3],
the barrier of hypoglycemia is the major limiting factor in
the maintenance of euglycemia [4]. Mild or self-treated
episodes of hypoglycemia are common, especially in type
1 diabetes, with reported rates of two episodes per week
[5]. Severe hypoglycemia, or episodes requiring external
assistance, may occur at least once a year, and are a signif-
icant cause of morbidity [5-7].
Although some episodes of severe hypoglycemia are
treated at home by administration of oral glucose or intra-
muscular glucagon by family members, the most severe
episodes require ambulance or emergency department
(ED) visits. Although ED visits for severe hypoglycemia
represent a small percentage of the total episodes of
hypoglycemia in diabetes, they do serve as a good epide-
miological marker of the complication and result in sig-
nificant economical and psychological costs [8].
Most data on the epidemiology of hypoglycemia are
based on highly selected patients in the setting of large
clinical trials [1-3,7], and may not generalize to the gen-
eral population. Accurate identification of hypoglycemia
cases by International Classification of Diseases, Ninth Revi-
sion, Clinical Modification (ICD-9-CM) codes may help to
describe the epidemiology, monitor trends, and propose
interventions to improve diabetes care through national
administrative databases and local chart reviews [9]. There
are several ICD-9-CM coding options for hypoglycemia,
some of which may represent other diagnoses. For exam-
ple, diabetes with other specified manifestations (250.8)
may represent hypoglycemia or diabetic lower extremity
ulcers. While several prior studies have utilized ICD-9-CM
codes to identify cases of hypoglycemia [10-14], only
Johnson et al. described the accuracy of ICD-9-CM codes
to identify hypoglycemia episodes, but with significant
methodological limitations [10].
Building on this prior work, we evaluated the accuracy a
new ICD-9-CM coding algorithm to identify cases of
hypoglycemia presenting to the ED. We hypothesized that
our proposed algorithm would identify hypoglycemia
with a positive predictive value (PPV) of at least 80%.
Methods
Study design
This was a multicenter, retrospective cohort study using a
structured medical record review for validation of a pro-
spectively derived ICD-9 coding algorithm. We obtained
ethics approval with a waiver of informed consent from
the Partners Human Research Committee and the Beth
Israel Deaconess Medical Center Committee on Clinical
Investigation.
Study setting and population
This study was conducted at three urban, academic EDs,
which are active participants in the Emergency Medicine
Network [15]. The EDs have a combined annual visit vol-
ume of 175,000 and are staffed by emergency medicine,
internal medicine, and surgery residents, and patient care
is supervised by attending emergency physicians 24
hours/day.
Study Protocol
Using the electronic medical records system at each site,
we searched the following ICD-9-CM codes to identify
possible visits for hypoglycemia: 250.3 (diabetes with
other coma), 250.8 (diabetes with other specified mani-
festations) 251.0 (hypoglycemic coma), 251.1 (other
specified hypoglycemia), 251.2 (hypoglycemia, unspeci-
fied), 270.3 (leucine-induced hypoglycemia), 775.0
(hypoglycemia in an infant born to a diabetic mother),
775.6 (neonatal hypoglycemia), and 962.3 (poisoning by
insulins and antidiabetic agents).
Given the diversity of potential ICD-9-CM codes, we
searched this broad range of codes and in all diagnosis
fields (up to ten listed) in an attempt to capture all possi-
ble ED hypoglycemia visits. For admitted patients, we
examined only ED-based codes, to avoid inclusion of inci-
dent hypoglycemia that occurred during inpatient hospi-
talization. In cases where multiple candidate codes were
present, we recorded only the first-listed code. The excep-
tion to this was for the more ambiguous codes 250.3 and
250.8, for which we preferentially recorded any of the
other candidate codes if present. We based this strategy on
detailed examination of the ICD-9-CM coding manual
[9], review of the experience from previously reported
approaches [10-14], and discussion with coding experts.
The code 250.8 may be used for other specific diabetes-
associated complications in addition to hypoglycemia,
including: 259.8 (secondary diabetic glycogenosis), 272.7
(diabetic lipidosis), 707.xx (ulcers of the lower extremity),
709.3 (Oppenheim-Urbach syndrome), and
730.0–730.2, 731.8 (osteomyelitis). Based on discussion
with coding experts, we determined that 681.xx (cellulitis
of fingers/toes), 682.xx (other cellulitis), and 686.9x
(local skin infection) may also be utilized as a co-diag-
noses for 250.8, although not specifically mentioned in
the manual. We prospectively proposed the coding algo-
rithm displayed in Figure 1 and validated its accuracy
through chart review.
We identified all ED visits with candidate ICD-9-CM
codes between July 1, 2005 and June 30, 2006 at each site,BMC Endocrine Disorders 2008, 8:4 http://www.biomedcentral.com/1472-6823/8/4
Page 3 of 7
(page number not for citation purposes)
ICD-9-CM coding algorithm to identify emergency department visits for hypoglycemia Figure 1
ICD-9-CM coding algorithm to identify emergency department visits for hypoglycemia. ICD-9-CM – International 
Classification of Diseases, Ninth Revision. * Consider exclusion of this code from algorithm, since positive predictive value was 
54% in this analysis, and exclusion improved the accuracy of the algorithm.
      Are any of the following ICD-9-CM codes present? 
All Hospital/Clinic 
Visits 
                    YES 
          N O  
        NO             Are any of the following co-diagnoses present? 
          YES  Is ICD-9-CM code 
250.8 present? 
(diabetes with 
other specified 
manifestations) 
251.0 (hypoglycemic coma)  
251.1 (other specified hypoglycemia) 
251.2 (hypoglycemia, unspecified)  
270.3 (leucine-induced hypoglycemia)  
775.0 (hypoglycemia in an infant born to 
a diabetic mother) 
775.6 (neonatal hypoglycemia) 
962.3
* (poisoning by insulins and 
antidiabetic agents) 
 
Include as visit 
for hypoglycemia 
              Y E S  
259.8 (secondary diabetic glycogenosis) 
272.7 (diabetic lipidosis) 
681.xx, 682.xx, 686.9x (cellulitis) 
707.1-707.9 (ulcers of the lower extremity) 
709.3 (Oppenheim-Urbach syndrome),  
730.0-730.2, 731.8 (osteomyelitis)) 
                  YES 
                     NO 
Is ICD-9-CM code 
250.3 (diabetes with 
coma) present? 
Unable to distinguish 
diabetic ketoacidosis 
and hypoglycemia-- 
Note for data quality.
Exclude as visit 
for hypoglycemiaBMC Endocrine Disorders 2008, 8:4 http://www.biomedcentral.com/1472-6823/8/4
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and obtained written ED charts. For patients with multi-
ple ED visits during the data collection period, we
requested only the first visit to avoid overrepresentation
by certain patients. Trained research staff abstracted all
charts using a standardized form, and the research group
met weekly to discuss data collection and resolve abstrac-
tion issues. Additionally, two reviewers independently
abstracted 10% of charts to evaluate inter-rater agreement
in data collection. To enhance the reliability of our chart
review, we abstracted only charts with complete ED triage
assessment, nursing notes, and emergency physician
notes and considered all other charts incomplete.
Key Outcome Measures
We considered this chart validation as the gold standard
for confirmation of true hypoglycemia visits. In reviewing
the ED chart, we confirmed cases of hypoglycemia based
on the following criteria: 1) Any documented pre-hospital
or ED glucose value (serum or capillary) 3.9 mmol/l, or 2)
Charted physician discharge diagnosis of hypoglycemia.
We based the glucose threshold on the consensus recom-
mendation defined by the American Diabetes Association
Workgroup on Hypoglycemia [16]. We included physi-
cian diagnosis of hypoglycemia to capture cases in which
hypoglycemia resolved prior to first glucose level, i.e.
patients receiving glucose for symptoms consistent with
hypoglycemia prior to blood glucose determination.
Additionally, we collected patient disposition (discharge
or hospital admission) to evaluate for differences in cod-
ing accuracy based on this factor.
Data analysis
We performed statistical analyses using Stata 9.0 (College
Station, TX). We summarized data using basic descriptive
statistics. We determined accuracy of specific codes and
coding algorithm by calculating PPV with 95% confidence
intervals (CI). Although we included a broad range of pos-
sible ICD-9-CM codes, the numbers of missed hypoglyc-
emia visits, not captured by the candidate codes, were
unknown. Under the ideal assumption that no cases were
missed, we calculated estimated point estimates for sensi-
tivity, specificity, and negative predictive values (NPV).
Additionally, we performed a sensitivity analysis by
increasing the presumed number of missed cases by 10%.
We determined inter-rater agreement for chart abstraction
by calculating the kappa statistic for the subgroup of
charts abstracted by two investigators. Additionally, we
compared accuracy of the algorithm stratified by candi-
date ICD-9-CM code position, study site and ED disposi-
tion using chi-squared test and with two-tailed p < 0.05
considered statistically significant. Finally, we evaluated
the accuracy of all ICD-9-CM codes to identify potential
improvements and calculated the accuracy of the revised
algorithm including the proposed modifications.
Results
Of the 174,134 ED visits at the three institutions during
the data collection period, we identified 901 patients with
candidate ICD-9-CM codes. These patients accounted for
1,139 visits with possible hypoglycemia (i.e., 0.5% of all
ED visits). We abstracted 679 charts (75% of visits by
unique patients) and excluded the remaining 222 patients
with missing or incomplete documentation. There were
no significant differences in age, sex, race/ethnicity, and
distribution of candidate ICD-9-CM codes comparing
abstracted and excluded patients (all p > 0.05).
Based on the chart review, we confirmed 436 (64%) cases
of hypoglycemia. Confirmation of hypoglycemia had a
very high inter-rater agreement (kappa = 0.97). Predictive
values for individual ICD-9-CM codes are presented in
Table 1. The majority (83%) of confirmed cases of
hypoglycemia were coded as 250.8.
Table 2 shows the accuracy of excluding hypoglycemia
cases for visits with ICD-9-CM code 250.8 using the pro-
posed alternate co-diagnoses. The absence of any co-diag-
Table 1: Predictive value of ICD-9-CM codes for identification of hypoglycemia
ICD-9-CM Code n (%) Confirmed Cases (%) PPV (95%CI)
250.30 1 (0.2) 1 (0.2) 100%
250.8x 586 (86) 363 (83) 62% (58–66)
Co-diagnoses absent* 385 (57) 353 (81) 92% (88–94)
251.10 3 (0.4) 2 (0.5) 67% (9–99)
251.20 64 (9) 56 (13) 88% (77–94)
775.60 1 (0.2) 1 (0.2) 100%
962.30 24 (4) 13 (3) 54% (32–74)
Algorithm+ 477 (70) 425 (97) 89% (86–92)
Total 679 436 64% (60–68)
ICD-9-CM – International Classification of Diseases, Ninth Revision; n – number; CI – confidence interval; PPV – positive predictive value.
* Co-diagnoses are: 259.8, 272.7, 681.xx, 682.xx, 686.9x, 707.xx, 709.3, 730.0–730.2, and 731.8.
+ Predictive value of proposed algorithm (see Figure 1)BMC Endocrine Disorders 2008, 8:4 http://www.biomedcentral.com/1472-6823/8/4
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nosis codes improved the positive predictive value of
250.8 from 62% to 92%, while excluding 10 (2%) of true
hypoglycemia visits. These false-negative cases occurred
when either cellulitis (681.xx, 682.xx, 686.9x) or ulcers
(707.xx) were present concurrently with hypoglycemia.
Overall, the proposed algorithm had PPV of 89% (95%CI,
86–92) for detecting hypoglycemia visits. There was no
significant difference in PPV when data were stratified by
site or by ED disposition (p = 0.86 and 0.22, respectively).
Based on the assumption that the candidate ICD-9-CM
codes captured all ED presentations with hypoglycemia,
we estimate that the algorithm had 97% sensitivity, >99%
specificity, and >99% NPV. Assuming the algorithm
missed at most 10% of hypoglycemia visits, we estimate a
minimum sensitivity of 88% with NPV and specificity
remaining >99%.
Table 3 presents the relationship between ICD-9-CM code
position and confirmed hypoglycemia cases, stratified by
the common candidate codes. Over a quarter of con-
firmed cases had a candidate code outside of the first-
listed diagnosis field. Algorithm codes in the first ICD-9-
CM position had a higher PPV for confirmed hypoglyc-
emia visits than other positions (93% vs. 81%, p < 0.01).
Post-hoc review of the algorithm performance suggested
that cases identified by 962.3 demonstrated low PPV
(54%), primarily representing patients with excessive
insulin or oral hypoglycemic use without development of
clinical or laboratory hypoglycemia. We evaluated the full
list of ICD-9-CM codes for all visits coded as 962.3 and
found that 10 of 13 confirmed cases of hypoglycemia had
250.8 listed as a co-diagnosis and only 1 of 11 cases with-
out hypoglycemia had 250.8 as a co-diagnosis. When we
removed 962.3 as a candidate code and relied only on
coding for 250.8 in these cases, the PPV for the overall
algorithm increased from 89% to 91% (95%CI, 88–93)
while the estimated sensitivity remained at 97%.
Discussion
In this study, we demonstrated high predictive value for
detection of ED hypoglycemia visits using the new ICD-9-
CM coding algorithm. To our knowledge, this is the first
chart validation of the accuracy of ICD-9-CM codes for
hypoglycemia, an important complication in diabetes
and common ED presentation.
Our algorithm differs in several important ways from
prior reports on hypoglycemia. Two separate analyses of
the relationship between anti-hypertensive agents and
hypoglycemia in patients with diabetes, Herings et al. and
Morris et al. used ICD-9-CM codes 251.0, 251.1, and
251.2 to identify possible episodes of hypoglycemia
[12,13]. Schorr et al. broadened candidate codes to
include 250.3 and 962.3 [11,14]. Notably, none of these
studies included 250.8 in their search strategies, nor
accounted these possible missed episodes of hypoglyc-
emia. In our analysis, 250.8 comprised the vast majority
(83%) of hypoglycemia cases, and exclusion of this code
in these prior studies likely contributed to substantial
underestimates in the incidence of hypoglycemia.
Johnson, et al. first reported the utility of 250.8 in their
strategy to identify ED visits for hypoglycemia [10]. In
their analysis, this code also identified over half of
hypoglycemia episodes and had a PPV of 73% for their
case definition of hypoglycemia. Our chart validation dif-
fered in several important ways. First, Johnson et al. lim-
ited their search to first-listed ICD-9-CM codes and
Table 2: Accuracy of co-diagnosis codes to exclude hypoglycemia for ICD-9-CM code 250.8
ICD-9-CM code* n (%) Valid exclusion (%) PPV (95%CI)
681.xx (cellulitis fingers/toes) 9 (4) 9 (5) 100%
682.xx (other cellulitis) 86 (43) 78 (41) 91% (83–96)
686.90 (local skin infection) 6 (3) 6 (3) 100%
707.xx (ulcers of lower limb) 92 (46) 90 (47) 98% (94–100)
730.27 (osteomyelitis ankle/foot) 2 (1) 2 (1) 100%
731.8 (other osteomyelitis) 6 (3) 6 (3) 100%
Total 201 191 95% (91–98)
ICD-9-CM – International Classification of Diseases, Ninth Revision; n – number; CI – confidence interval; PPV – positive predictive value.
* No observations for 259.8 (secondary diabetic glycogenosis), 272.7 (diabetic lipidosis), or 709.3 (Oppenheim-Urbach syndrome)
Table 3: Association between diagnostic code position and 
identification of hypoglycemia
Total confirmed hypoglycemia cases
ICD-9-CM position n (%) 250.8x 251.20 962.30 Other
1st 319 (73) 287 18 12 2
2nd 85 (19) 55 29 0 1
3rd 21 (5) 14 6 0 1
4th or higher 11 (3) 7 3 1 0
Total 436 363 56 13 4
ICD-9-CM – International Classification of Diseases, Ninth RevisionBMC Endocrine Disorders 2008, 8:4 http://www.biomedcentral.com/1472-6823/8/4
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excluded all other diagnosis fields. We evaluated all diag-
nosis fields and while candidate codes in the first diagno-
sis field had a higher PPV, limitation to the primary
diagnosis field would have excluded 27% of hypoglyc-
emia cases. Additionally, candidate codes in the latter
diagnosis fields maintained a high PPV (81%). Secondly,
their validation of hypoglycemia cases involved searching
of brief communications following the ED visit for symp-
toms consistent with hypoglycemia, which included con-
fusion, loss of consciousness, and seizure. While these
symptoms are consistent with hypoglycemia, they are
nonspecific and have many other causes in addition to
hypoglycemia [17]. We performed detailed chart reviews
to confirm hypoglycemia visits, which allowed for more
precise validation. Finally, we confirmed the importance
of 250.8 in identification of the majority of hypoglycemia
visits, but additionally refined the search strategy by exclu-
sion of visits with alternate co-diagnoses. Exclusion of
these cases reliably eliminated 85% of false-positive cases
coded as 250.8, while eliminating only a small number of
true-positive cases.
Overall, 250.8 with exclusion of alternate co-diagnoses
and 251.2 comprised >95% of hypoglycemia identified by
the algorithm. Although there were insufficient data to
evaluate 250.0 and 250.1 in this analysis, we recommend
inclusion of these codes in any search for hypoglycemia.
These codes are likely to have high specificity/PPV, and
their utilization may be higher in different institutions
and practice environments. As anticipated, codes 270.3,
775.0 and 775.6 were rare in the ED setting but may have
utility for other settings, such as maternity and neonatal
units.
We hypothesized that we would not be able to determine
if diabetes with other coma (250.3) were caused by
hypoglycemia or diabetic ketoacidosis (DKA). There were
insufficient data to evaluate this hypothesis (only one
case), and charts identified with this code should be inter-
preted with caution. Compared to prior 100% PPV in
prior analysis [10], we were surprised by the relatively low
predictive value (54%) of 962.3. Based on this finding
and our secondary analysis, we recommend exclusion of
962.3 and relying only on 250.8 to identify most of these
associated visits. This proposed strategy will require vali-
dation in other institutions and settings.
The ICD-9-CM classification system is imperfect for case
identification, as it was created for reimbursement rather
than research purposes [18]. Given this inherent limita-
tion, the proposed algorithm for hypoglycemia compares
favorably to those suggested for a variety of diseases. ICD-
9-CM coding accuracy for upper gastrointestinal disorders
(93–95% PPV) and Clostridium difficile colitis (87%
PPV) were similar [19,20], but were more unreliable for
stroke (61–79% PPV) [21], soft tissue disorders (64%
PPV) [22], pneumococcal pneumonia (58% PPV) [23],
traumatic brain injury (20–38% PPV) [24], and venous
thromboembolism (31% PPV) [25]. Based on these com-
parisons, the proposed ICD-9-CM coding algorithm for
hypoglycemia would be expected to perform as well or
better than coding strategies for other diagnoses in accu-
rate case identification from administrative data.
Limitations
The current study has some potential limitations. We did
not abstract the 25% of charts that were missing or incom-
plete. While this lowered the number of total cases, the
distribution of ICD-9-CM codes was similar in abstracted
and non-abstracted charts, and the likelihood of biased
accuracy estimates was small. The coding of hypoglycemia
visits was based on three academic EDs and may not gen-
eralize to other areas of the hospital, outpatient providers,
and other geographic areas. However, there are a finite
number of options for coding hypoglycemia, and
although the frequency of individual code usage will
likely vary based on local practice and familiarity of the
coding personnel, we anticipate that accuracy will not
vary substantially. We were unable to formally evaluate
false-negatives in our data set. Thus, we were only able to
calculate PPV with accuracy, and our estimates for sensi-
tivity, specificity, and NPV are significantly limited. To
help address this limitation, we performed a sensitivity
analysis, which demonstrated a high level of accuracy
even when we increased the assumption of missed cases,
but inferences based on these values should be guarded.
Finally, the accuracy of case confirmation by chart review
depended on a retrospective evaluation for hypoglycemia,
which may overestimate or underestimate the true
number of cases. Standardized definitions and training of
reviewer limited the potential for such bias, and high
inter-rater agreement demonstrated internal reliability of
the chart review.
Conclusion
We derived and validated a new ICD-9-CM coding algo-
rithm to identify hypoglycemia visits with high predictive
validity. This algorithm improves on prior strategies to
identify hypoglycemia cases in administrative data sets
and will enhance the ability to study the epidemiology
and design interventions for this important complication
of diabetes care.
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